Phase 3 Results of Fixed -Dose Combination of Remogliflozin Etabonate and Vildagliptin in Indian T2DM Patients

被引：0
|
作者：
Mohan, Brij
Chawla, Manoj S.
Kodgule, Rahul R.
Tandon, Monika
Katare, Sagar
Suryawanshi, Sachin
Barkate, Hanmant V.
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-800-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
800-P
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Results from a dietary survey in an Indian T2DM population: a STARCH study
    Joshi, Shashank R.
    Bhansali, Anil
    Bajaj, Sarita
    Banzal, Subodh S.
    Dharmalingam, Mala
    Gupta, Shachin
    Mukhopadhyay, Satinath
    Shah, Parag R.
    Sahay, Rakesh
    Sarkar, Swapan
    Manjrekar, Pravin V.
    Rathod, Rahul T.
    Joshi, Shilpa S.
    BMJ OPEN, 2014, 4 (10):
  • [22] Efficacy and Safety of Vildagliptin in Triple Combination With Metformin Plus Sulfonylurea in Subgroup of Patients With T2DM and Baseline HbA1c
    Lukashevich, Valentina
    Araga, Mako
    Kothny, Wolfgang
    DIABETES, 2013, 62 : A294 - A294
  • [23] Effects of vildagliptin versus saxagliptin on daily acute glucose fluctuations in Chinese patients with T2DM inadequately controlled with a combination of metformin and sulfonylurea
    Chen Xiaoyan
    Wang Jing
    Huang Xiaochun
    Tan Yuyu
    Deng Shunyou
    Fu Yingyu
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (06) : 1131 - 1136
  • [24] Effect of a Single Dose of Canakinumab on hsCRP Levels in T2DM Patients
    Howard, Campbell
    Noe, Adele
    Taylor, Ann
    Thuren, Tom
    DIABETES, 2013, 62 : A113 - A113
  • [25] Repaglinide/metformin fixed-dose combination tablet vs. rosiglitazone/metformin fixed-dose combination tablet in T2DM subjects evaluated by prior OAD treatment regimen
    Rhee, Chanhaeng
    Hang, Yaming
    Lyness, William
    Raskin, Philip
    DIABETES, 2008, 57 : A586 - A587
  • [26] Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes (T2DM) and mild hyperglycemia
    Scherbaum, W. A.
    Schweizer, A.
    Mari, A.
    Nilsson, P. M.
    Lalanne, G.
    Jauffret, S.
    Foley, J. E.
    DIABETES, 2007, 56 : A134 - A134
  • [27] A Multicenter, Randomized, Double-Blind Study to Compare the Safety and Efficacy of Sitagliptin/Metformin Fixed-Dose Combination to Glimepiride in Patients with T2DM
    Kim, Sang Soo
    Park, Jeong Hyun
    Lee, Kwang Jae
    Chung, Sung Chang
    Kim, Young Il
    Lee, Young Sil
    Lee, Sang Jin
    Kim, In Joo
    DIABETES, 2015, 64 : A654 - A655
  • [28] Clinical characteristics of T2DM patients diagnosed with HFpEF: An Indian pilot survey
    Ghosal, S.
    Kovil, R.
    Sinha, B.
    Ved, J.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [29] Harmony 2 Year 3 Results: Albiglutide Monotherapy in Drug-Naive Patients with T2DM
    Rendell, Marc
    Perkins, Christopher
    Scott, Rhona A.
    Ye, June
    Stewart, Murray W.
    Carr, Molly C.
    Nauck, Michael A.
    DIABETES, 2014, 63 : A245 - A246
  • [30] Vildagliptin decreases postprandial chylomicron triglycerides (TGs) in drug-naive patients with type 2 diabetes (T2DM)
    Matikainen, Niina
    Manttari, Sakari
    Schweizer, Anja
    Ulvestad, Anne
    Mills, David
    Dunning, Beth E.
    Foley, James E.
    Taskinen, Marja-Riitta
    DIABETES, 2006, 55 : A125 - A125
12345